CoChat

Caveolin‐1 is essential for metformin inhibitory effect on IGF1 action in non‐small‐cell lung cancer cells

Salani, Barbara, Maffioli, Sara, Hamoudane, Meriem, Parodi, Alessia, Ravera, Silvia, Passalacqua, Mario, Alama, Angela, Nhiri, Mohamed, Cordera, Renzo, Maggi, Davide · 2012 · The FASEB Journal
Cited by 73

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Metformin causes an AMP/ATP ratio increase and AMP‐activated protein kinase (AMPK) activation. Since caveolin‐1 (Cav‐1) plays a role in AMPK activation and energy balance, we investigated whether Cav‐1 could participate in metformin's inhibitory effect on IGF1 signaling. The effect of metformin was studied in two non‐small‐cell lung cancer (NSCLC) cell lines, Calu‐1 and Calu‐6, expressing higher and lower amounts of Cav‐1, respectively. In Calu‐1, but not in Calu‐6 cells, metformin reduced phosphorylation of type 1 insulin‐like growth factor receptor (IGF‐IR) substrates Akt and Forkhead transcription factor 3a (FOXO3a), inhibited IGF1‐dependent FOXO3a nuclear exit, and decreased IGF1‐dependent cell proliferation. Here, we show that sensitivity of NSCLC cells to metformin was dependent on Cav‐1 expression and that metformin required Cav‐1 to induce AMPK phosphorylation and AMP/ATP ratio increase. Cav‐1 silencing in Calu‐1 and overexpression in Calu‐6 reduced and improved, respectively, the inhibitory effect of metformin on IGF1‐dependent Akt phosphorylation. Prolonged metformin treatment in Calu‐6 cells induced a dose‐dependent expression increase of Cav‐1 and OCT1, a metformin transporter. Cav‐1 and OCT1 expression was associated with the antiproliferative effect of metformin in Calu‐6 cells (IC 50 =18 mM). In summary, these data suggest that Cav‐1 is required for metformin action in NSCLC cells.—Salani, B., Maffioli, S., Hamoudane, M., Parodi, A., Ravera, S., Passalacqua, M., Alama, A., Nhiri, M., Cordera, R., Maggi, D. Caveolin‐1 is essential for metformin inhibitory effect on IGF1 action in non‐small‐cell lung cancer cells. FASEB J. 26, 788–798 (2012). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.11-192088

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

Metadata

Authors
Salani, B., Maffioli, S., Hamoudane, M., Parodi, A., Ravera, S., Passalacqua, M., Alama, A., Nhiri, M., Cordera, R., & Maggi, D.
Venue
The FASEB Journal
Publisher
Wiley
Published
2011-10-28
Volume
26
Issue
2
Pages
788-798
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2104242851
Cited by
73
References
13
FWCI
1.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.